中洲控股(000042.SZ):中洲置地質押9100萬股
格隆匯1月14日丨中洲控股(000042.SZ)公佈,公司於2020年1月14日收到公司股東深圳市中洲置地有限公司(“中洲置地”)的告知函,告知公司中洲置地通過中國證券登記結算有限責任公司辦理了證券質押登記手續,並於2020年1月14日取得相應的《證券質押登記證明》,此次質押9100萬股。
中洲置地及其一致行動人未來半年內到期的質押股份累計數量為1.1374億股,佔其合計所持股份比例33.79%,占上市公司總股本比例17.11%,對應融資餘額為7億元;未來一年內到期(不含半年內到期)的質押股份累計數量為0。中洲置地的還款資金來源包括但不限於公司經營利潤、投資收益等,具備資金償付能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.